Amarin Corp Plc (AMRN)

[north40000]

dogn, I suggest that all here look for the Corporate Call and Q4 update for March 13, 2004 at Investor.Sangamo.com. I found this presentation on the ANI Pharmaceutical IHub board at post #14792. The 42 slides(reflecting preclinical research in animals) are impressive. (My hope is that the researchers at the U.Wisconsin have completed or are currently assessing the cells of human patients in the Amarin-funded BRAVE trial using the same or similar technology). The SGMO cell images appear to be enabled by NVDA AI technology/chips, and have caused SGMO to change its business model to focus on development of technology in 4 areas of the brain, e.g., prion disease and Alzheimer’s disease, as well as novel chronic neuropathic pain therapeutics. PFE is financing the preclinical Prion Disease and AD area so far, and Alexion and Takeda are partners in 2 other areas